Post Viral Bacterial Pneumonia: Role of MicroRNA and Autophagy
病毒性细菌性肺炎后:MicroRNA 和自噬的作用
基本信息
- 批准号:9247795
- 负责人:
- 金额:$ 38.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2019-01-20
- 项目状态:已结题
- 来源:
- 关键词:AddressAnti-Bacterial AgentsAntibacterial ResponseAutophagocytosisBacteriaBacterial InfectionsBacterial PneumoniaCause of DeathCessation of lifeDevelopmentExcisionExperimental ModelsFailureGoalsGrantHost DefenseITGAM geneImmune responseImpairmentInfectionInfluenzaInterferon Type IIInterferon-alphaLoxP-flanked alleleLungMediatingMicroRNAsMorbidity - disease rateMusNatural ImmunityOutcomePatientsPhagocytosisPneumococcal InfectionsPneumoniaProductionRecruitment ActivityRegulationRoleSecondary PreventionSirolimusStaphylococcal InfectionsStreptococcus pneumoniaeTestingTherapeuticTransgenic MiceUnited StatesUp-RegulationViralVirus Diseasesattributable mortalitycell typecytokineimprovedimproved outcomeinhibition of autophagyinsightkillingsmacrophagemethicillin resistant Staphylococcus aureusmortalitymouse modelneutralizing monoclonal antibodiespathogenpreventpublic health relevancereceptorresponsesuperinfectiontherapeutic targettherapy development
项目摘要
DESCRIPTION (provided by applicant): Influenza infections are a leading cause of death in the United States and worldwide, with 50 000 of deaths occurring annually in the United states alone. Although many patients succumb to the primary viral infection, a significant number of influenza-related deaths are attributable to the development of secondary bacterial infections. Why the host is more susceptible to bacterial infections post-influenza is poorly understood. A better understanding of how the host responds to sequential influenza + bacterial infection is necessary in order to develop therapies to improve outcomes. Using a murine model of sequential pulmonary influenza and methicillin-resistant Staphylococcus aureus (MRSA) or Streptococcus pneumoniae infection, we have found that these mice have decreased survival and impaired anti-bacterial responses. We also showed that host responses to post-viral pneumonia are characterized by impaired macrophage autophagy responses, and impaired macrophage phagocytosis and killing of bacteria in the lungs. These findings correlate with significant upregulation of interferon (IFN)γ and upregulation of miR 155 when compared to mice infected with either pathogen alone. Thus, we hypothesize that impaired innate immunity against MRSA in the setting of post-influenza pneumonia is due to IFNγ-induced upregulation of miR 155 which in turn blocks protective autophagy responses and prevents bacterial phagocytosis and killing. We will address these goals with the following specific aims. Aim 1) To determine the role of IFNγ in regulating miR 155 expression, host defense, cytokine production, and macrophage autophagy following infection with influenza alone, MRSA/Streptococcus pneumoniae alone or sequential infection. This aim will characterize these outcomes in single and sequential infections, will test responses in chimeric mice generated using wild-type and IFNγ
receptor-/- mice and will test a therapeutic approach to block IFNγ using a neutralizing mAb. Aim 2) To determine whether the impaired host defense noted during post-viral pneumonia is due to a failure of lung macrophages to upregulate protective autophagy responses This aim will determine whether autophagy is impaired in lung macrophages post- sequential infection compared to single infection, whether this is correlated with miR 155 inhibition of DAPK1 and whether enhancement of autophagy using rapamycin/Tat Beclin-1 can improve host defense by increasing bacterial phagocytosis and killing. Aim 3) To identify the mechanism that miR-155 uses to regulate macrophage recruitment, autophagy and to impair the anti-bacterial host-defense. This aim will characterize expression of miR 155 during post-viral pneumonia and explore inhibition of autophagy during post-viral pneumonia as a result of miR 155 inhibition of DAPK1. The ability of miR 155 to regulate bacterial phagocytosis and killing also will be explored. Additionally, transgenic mice will be generated using floxed miR155 and CD11b-Cre mice enabling cell type specific removal of miR155 from macrophages further providing mechanistic insight regarding regulation of autophagy by miR 155 expression on macrophages.
描述(由申请人提供):流感感染是美国和世界范围内死亡的主要原因,仅在美国每年就有5万人死亡。尽管许多患者死于原发性病毒感染,但相当数量的流感相关死亡可归因于继发性细菌感染的发展。为什么宿主在流感后更容易受到细菌感染尚不清楚。为了开发改善结果的治疗方法,更好地了解宿主对连续流感+细菌感染的反应是必要的。使用小鼠序列性流感和耐甲氧西林金黄色葡萄球菌(MRSA)或肺炎链球菌感染模型,我们发现这些小鼠的存活率下降,抗菌反应受损。我们还发现,宿主对病毒后肺炎的反应以巨噬细胞自噬反应受损、巨噬细胞吞噬和肺部细菌杀伤受损为特征。与单独感染任一病原体的小鼠相比,这些发现与干扰素(IFN)γ的显著上调和miR 155的上调相关。因此,我们假设在流感后肺炎的情况下,对MRSA的先天免疫受损是由于ifn γ诱导miR 155的上调,miR 155反过来阻断保护性自噬反应,阻止细菌吞噬和杀伤。我们将通过以下具体目标来实现这些目标。目的1)确定IFNγ在流感单独感染、MRSA/肺炎链球菌单独感染或序列感染后调节miR 155表达、宿主防御、细胞因子产生和巨噬细胞自噬中的作用。该目标将在单次和连续感染中描述这些结果,并将测试使用野生型和IFNγ产生的嵌合小鼠的反应
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bethany B. Moore其他文献
The Role of CXC Chemokines in the Regulation of Angiogenesis in Association with Non-Small-Cell Lung Cancer
CXC趋化因子在调节与非小细胞肺癌相关的血管生成中的作用
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
R. Strieter;Christina L. Addison;Bethany B. Moore;D. Arenberg - 通讯作者:
D. Arenberg
Exacerbation of Established Pulmonary Fibrosis in a Murine Model by Gammaherpesvirus at a Glance Commentary
伽玛疱疹病毒引起的小鼠模型中已建立的肺纤维化的恶化概览
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
T. Mcmillan;Bethany B. Moore;Jason B Weinberg;Kevin M. Vannella;W. B. Fields;P. J. Christensen;L. V. van Dyk;G. Toews - 通讯作者:
G. Toews
Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation
- DOI:
10.1007/s00005-007-0001-2 - 发表时间:
2007-01-15 - 期刊:
- 影响因子:3.900
- 作者:
Megan N. Ballinger;Tracy R. McMillan;Bethany B. Moore - 通讯作者:
Bethany B. Moore
Ineffectual AEC2-to-AEC1 Differentiation in IPF: Persistence of KRT8hi Transitional State.
IPF 中 AEC2 到 AEC1 的无效分化:KRT8hi 过渡状态的持续存在。
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:24.7
- 作者:
P. Jiang;Rafael Gil de Rubio;S. Hrycaj;S. Gurczynski;Kent A. Riemondy;Bethany B. Moore;M. Omary;Karen M. Ridge;R. Zemans - 通讯作者:
R. Zemans
Dendritic Cell – Fibroblast Crosstalk via TLR9 and AHR Signaling Drives Lung Fibrogenesis
树突状细胞 - 通过 TLR9 和 AHR 信号传导的成纤维细胞串扰驱动肺纤维化
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
H. Carter;Rita Medina Costa;Taylor Sterling Adams;Talon Gilchrist;Claire E. Emch;Monica Bame;J. Oldham;A. Linderholm;I. Noth;Naftali Kaminski;Bethany B. Moore;S. Gurczynski - 通讯作者:
S. Gurczynski
Bethany B. Moore的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bethany B. Moore', 18)}}的其他基金
HSCT-induced alterations in DCs to promote IL-17 and lung pathology
HSCT 诱导的 DC 改变促进 IL-17 和肺部病理学改变
- 批准号:
9276115 - 财政年份:2016
- 资助金额:
$ 38.75万 - 项目类别:
miR-29b and autophagy regulate alveolar macrophage function post-BMT
miR-29b 和自噬调节 BMT 后肺泡巨噬细胞功能
- 批准号:
8864133 - 财政年份:2015
- 资助金额:
$ 38.75万 - 项目类别:
miR-29b and autophagy regulate alveolar macrophage function post-BMT
miR-29b 和自噬调节 BMT 后肺泡巨噬细胞功能
- 批准号:
9189677 - 财政年份:2015
- 资助金额:
$ 38.75万 - 项目类别:
Post Viral Bacterial Pneumonia: Role of MicroRNA and Autophagy
病毒性细菌性肺炎后:MicroRNA 和自噬的作用
- 批准号:
9038427 - 财政年份:2014
- 资助金额:
$ 38.75万 - 项目类别:
相似海外基金
New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
- 批准号:
1654774 - 财政年份:2015
- 资助金额:
$ 38.75万 - 项目类别:
Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
- 批准号:
8416313 - 财政年份:2012
- 资助金额:
$ 38.75万 - 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
- 批准号:
8298885 - 财政年份:2012
- 资助金额:
$ 38.75万 - 项目类别:














{{item.name}}会员




